You are now leaving the website.

The linked sites are not under the control of Amgen, and Amgen is not responsible for the content available on the linked sites. Such links do not imply Amgen's endorsement of material on any other site, and Amgen disclaims all liability with regard to your access to such linked websites. Amgen provides links to other Internet sites as a convenience to users, and access to such linked sites is at your own risk.


My Time My Voice: Episode 3 – For Your Information

My Time My Voice: Episode 3 – For Your Information

If you’re a cancer patient, everything you do — everything your body does — can potentially generate data. The growth or regression of a tumour? That’s information. Your white blood cell count is information. Even your mental state along your journey is information that could be medically useful.

Data fuels innovation. And researchers and oncologists are using patient data to refine and personalize treatment. But as our guest Helen Chen explains our medical data is often siloed in Canada. Fragmented. And it’s not standardized. What can we do to make our data work better for researchers and oncologists in the fight against cancer?

“Data helps inform the research into new treatments from the very early stages, and then later we need data to match the treatment to the patient.”
— Helen Chen

Play Episode

in this episode

Guest: Helen Chen
A Professor in the School of Public Health and Health Systems at the University of Waterloo, Dr. Chen is an expert in health data quality and analytics, specifically modernizing data gathering and rules around consent and sharing for research purposes. 
Host: Michelle Jobin
Michelle is a TV personality, producer and writer with more than a decade of experience in broadcast and online media covering lifestyle, weather and news content.

Listen on

spotify podcast googlepodcast

Do you want to link to our other external sites and leave

You are now leaving the Amgen Canada website. Please note that the information you are about to view may not comply with Canadian regulatory requirements. Marketing authorizations and availability of products may differ between Canada and other countries.